095700 Stock Chart & Stats
₩3325.00
₩325.00(10.83%)
―
--
Day’s Range― - ―
52-Week Range₩2,140.00 - ₩7,490.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)146.07K
Market Cap
₩136.44B
Enterprise Value₩203.90K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.13
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding45,540,493
10 Day Avg. Volume78,803
30 Day Avg. Volume146,072
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Genexine, Inc. News
095700 FAQ
What was Genexine, Inc.’s price range in the past 12 months?
Genexine, Inc. lowest stock price was ₩2140.00 and its highest was ₩7490.00 in the past 12 months.
What is Genexine, Inc.’s market cap?
Genexine, Inc.’s market cap is ₩136.44B.
When is Genexine, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genexine, Inc.’s earnings last quarter?
Currently, no data Available
Is Genexine, Inc. overvalued?
According to Wall Street analysts Genexine, Inc.’s price is currently Undervalued.
Does Genexine, Inc. pay dividends?
Genexine, Inc. does not currently pay dividends.
What is Genexine, Inc.’s EPS estimate?
Genexine, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genexine, Inc. have?
Genexine, Inc. has 45,540,493 shares outstanding.
What happened to Genexine, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genexine, Inc.?
Currently, no hedge funds are holding shares in KR:095700
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JEIL PHARMA HOLDINGS INC.
―
T&R Biofab Co., Ltd
―
Keeps Biopharma Inc.
―
Aptabio Therapeutics, Inc.
―
TiumBio Co., Ltd.
―
